Rena M. Conti, Ph.D., is an expert on the financing, regulation and organization of medical care, with an emphasis on biopharmaceutical markets and oncology practice. She is an Associate Professor of Health Policy in the Department of Pediatrics and the Department of Health Studies at the University of Chicago. Dr. Conti is a 2007 graduate of the Harvard University Interfaculty Initiative in health policy. She currently serves on the Government Affairs committee for the American Society of Clinical Oncology and is co-director of the economics working group for Cancer Therapy Evaluation Program for the National Cancer Institute.

David Goldhill is president and CEO of GSN, which operates a US cable television network seen in more than 80 million homes and one of the world’s largest digital games companies.  GSN is owned by Sony Pictures Entertainment and DIRECTV. Goldhill is the author of “Catastrophic Care: Why Everything We Think We Know about Health Care is Wrong” (Knopf, January 2013), an original investigation on healthcare in America, why it is failing, and how it can be transformed. Acclaimed author Malcolm Gladwell called “Catastrophic Care” “a devastating and utterly original analysis of what has gone wrong with the American health care system” and Publisher’s Weekly cited the book as a “fascinating and infuriating expose of the American health care system.”

Goldhill regularly speaks on health care topics, having recently appeared at events sponsored by Harvard Medical School, Rand, Duke University, Vanderbilt University, the Institute of Medicine, Manhattan Institute, World Health Care Congress and the Association of Healthcare Journalists.  Goldhill published a notable cover story in the 2009 issue of The Atlantic magazine, entitled “How American Health Care Killed My Father,” and has written opinion pieces for The New York Times, The Wall Street Journal, The Washington Post, Time, and Bloomberg View. He has appeared extensively on television and radio, including on NPR, CNN, Fox News and MSNBC.

Prior to joining GSN, Goldhill was chairman and CEO of Independent Network Holdings, Ltd. (INTH), which founded and operated the TV3 television network in Russia through its sale to the Interros Group in December of 2006. He also served as president and COO of Universal Television Group, a division of Universal Studios. In this capacity, he oversaw all operations at the company’s domestic and international cable television networks (including USA and SciFi), cable and network television studios, first-run syndication business and worldwide television distribution. Goldhill was also the CFO of Act III Communications, a privately-owned holding company with interests in television stations, movie theaters, magazines, and film/television production.  He began his career as an investment banker with Morgan Stanley and Lehman Brothers.  He is a member of the Board of Directors of the Leapfrog Group, an employer-sponsored organization dedicated to hospital safety and transparency.

Goldhill graduated from Harvard University with a B.A. degree in history and holds an M.A. degree in history from New York University. 

Paul Howard is a senior fellow at the Manhattan Institute and director of health policy. He is a contributor to The Apothecary, the Forbes blog on health-care policy and entitlement reform, and a regular columnist for The Morning Consult. Along with Peter Huber, he is the co-author of Unlocking Precision Medicine (Encounter Books, 2016).

Howard has written on a wide variety of medical-policy issues, including FDA reform, biopharmaceutical innovation, consumer-driven health care, and Medicare and Medicaid reform. He is often quoted on health-care issues, and his work has appeared in such publications as Bloomberg View, New York Times, Wall Street Journal, National Affairs, USA Today, RealClearPolitics, New York Post, Investor’s Business Daily, Health Affairs, and FoxNews.com. He is a member of MI’s Project FDA.

Howard was part of the health-care policy advisory group for Mitt Romney’s 2012 presidential campaign, has testified twice before Congress, and, during 2013–16, served on an expert panel as a judge for Celgene’s Innovation Impact Awards. He joined MI in 2000, as deputy director of its Center for Legal Policy, where he edited research papers, managed legal-policy analyses, and organized conferences. He holds a B.A. from the College of the Holy Cross and a Ph.D. in political science from Fordham University.